Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma

Hematological Oncology

Volumn 16, Issue 2, 1998, Pages 47-55

  Pratt, G ^a   Wiles, M E ^a   Rawstron, A C ^a   Davies, F E ^a   Fenton, J A L ^a   Proffitt, J A ^a   Child, J A ^a   Smith, G M ^a   Morgan, G J ^a,b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Daunorubicin; Doxorubicin; Liposomes; Multiple myeloma

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DEXAMETHASONE; LOMUSTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SCREENING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE MYELOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DAUNORUBICIN; DRUG CARRIERS; HUMANS; LIPOSOMES; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0032434667     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199806)16:2<47::AID-HON622>3.0.CO;2-3     Document Type: Article

References (4)

1. 99mTc-labeled liposomes in patients with cancer. Cancer Res. 1984, 44, 375-378.
2. Storm, G., Roerdink, F. H., Steerenberg, P. A., de Johng, W. H., Crommelin, D. J. A. Influence of lipid composition on the antitumour activity exerted by doxorubicin-containing liposomes in a rat solid tumour model. Cancer Res. 1987, 47, 3366.
3. Storm, G., van Bloois, L., Steerenberg, P. A., van Etten, E., de Groot, G., Crommelin, D. J. A. Liposome encapsulation of doxorubicin: pharmaceutical and therapeutic aspects. J. Contrl. Release 1989, 9, 215.
4. Rahman, A., White, G., More, N., Schein, P. S. Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. Cancer Res. 1985, 45, 796-803.